Analyst Ratings For NASDAQ:MGLN – Magellan Health (NASDAQ:MGLN)
Today, NASDAQ:MGLN – Magellan Health (NASDAQ:MGLN) stock received an upgrade by Raymond James from Market Perform to Outperform.
Some recent analyst ratings include
- 5/1/2018-Raymond James Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
- 3/15/2018-Leerink Swann Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
- 10/13/2017-Jefferies Group Reiterated Rating of Buy.
Recent Insider Trading Activity For NASDAQ:MGLN – Magellan Health (NASDAQ:MGLN)
NASDAQ:MGLN – Magellan Health (NASDAQ:MGLN) has insider ownership of 4.60% and institutional ownership of 96.49%.
- On 4/2/2018 Barry M Smith, CEO, sold 13,375 with an average share price of $103.52 per share and the total transaction amounting to $1,384,580.00.
- On 3/5/2018 Daniel N Gregoire, General Counsel, sold 22,875 with an average share price of $99.05 per share and the total transaction amounting to $2,265,768.75.
- On 3/5/2018 Mostafa Kamal, CEO, sold 15,428 with an average share price of $99.04 per share and the total transaction amounting to $1,527,989.12.
- On 3/1/2018 Barry M Smith, CEO, sold 13,375 with an average share price of $101.20 per share and the total transaction amounting to $1,353,550.00.
- On 2/1/2018 Barry M Smith, CEO, sold 13,375 with an average share price of $99.20 per share and the total transaction amounting to $1,326,800.00.
- On 1/2/2018 Barry M Smith, CEO, sold 13,367 with an average share price of $95.94 per share and the total transaction amounting to $1,282,429.98.
- On 1/2/2018 Jonathan N Rubin, CFO, sold 17,443 with an average share price of $96.07 per share and the total transaction amounting to $1,675,749.01.
Recent Trading Activity for NASDAQ:MGLN – Magellan Health (NASDAQ:MGLN)
Shares of NASDAQ:MGLN – Magellan Health closed the previous trading session at 85.85 up +2.00 2.39% with 87.0 shares trading hands.